Literature DB >> 20538321

Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice.

Trinity J Bivalacqua1, Ashley E Ross, Travis D Strong, Milena A Gebska, Biljana Musicki, Hunter C Champion, Arthur L Burnett.   

Abstract

OBJECTIVES: The Ras homolog gene family, member A (RhoA) and its main downstream effector, Rho-kinase (ROCK) are important in maintaining the penis in the flaccid state. The pathophysiology of sickle cell disease-associated priapism is not well defined. We hypothesized that the RhoA/ROCK vasoconstrictive pathways might be involved in the development of priapism. Therefore, the objective of the present study was to evaluate the molecular changes in RhoA and ROCK in an established transgenic sickle cell mouse model of priapism.
METHODS: Two groups of mice were used: wild type (WT; C57BL/6) mice and transgenic sickle cell mice. We evaluated RhoA guanosine triphosphatase and total ROCK activities, as well as ROCK1 and ROCK2 protein expression, in WT and sickle mice penises. We also evaluated the in vivo erectile responses to cavernous nerve stimulation and the frequency and duration of spontaneous erections before and after cavernous nerve stimulation.
RESULTS: Sickle mice demonstrated significantly (P <.05) enhanced erectile responses to cavernous nerve stimulation and frequency of spontaneous erections both before and after cavernous nerve stimulation compared with the WT mice. The sickle mice penises had a significant decline in RhoA guanosine triphosphatase (P <.01) and total ROCK activities (P <.05) compared with the WT mice. A significant (P <.05) reduction in ROCK2 protein expression in sickle mice penises compared with WT mice protein expression. No change in ROCK1 protein expression was observed in either cohort of mice penises.
CONCLUSIONS: These data suggest that sickle cell disease associated-priapism might be contributed by a lack of RhoA/ROCK-mediated vasoconstriction and highlight a novel molecular mechanism in the pathophysiology of priapism. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538321      PMCID: PMC3762569          DOI: 10.1016/j.urology.2010.02.050

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  25 in total

1.  Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.

Authors:  K Chitaley; C J Wingard; R Clinton Webb; H Branam; V S Stopper; R W Lewis; T M Mills
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

2.  Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.

Authors:  Lewis L Hsu; Hunter C Champion; Sally A Campbell-Lee; Trinity J Bivalacqua; Elizabeth A Manci; Bhalchandra A Diwan; Daniel M Schimel; Audrey E Cochard; Xunde Wang; Alan N Schechter; Constance T Noguchi; Mark T Gladwin
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

3.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.

Authors:  Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway.

Authors:  Mário Angelo Claudino; Carla Fernanda Franco-Penteado; Marcus Alexandre Finzi Corat; Ana Paula Gimenes; Luiz Augusto Correa Passos; Edson Antunes; Fernando Ferreira Costa
Journal:  J Sex Med       Date:  2009-06-02       Impact factor: 3.802

5.  Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.

Authors:  Christopher J Wingard; Fatiha Moukdar; Raju Y Prasad; Brook L Cathey; Lois Wilkinson
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

6.  ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells.

Authors:  Yuepeng Wang; Xiaoyu Rayne Zheng; Nadeene Riddick; Meredith Bryden; Wendy Baur; Xin Zhang; Howard K Surks
Journal:  Circ Res       Date:  2009-01-08       Impact factor: 17.367

7.  Ketoconazole and prednisone to prevent recurrent ischemic priapism.

Authors:  Michael R Abern; Laurence A Levine
Journal:  J Urol       Date:  2009-08-15       Impact factor: 7.450

8.  Y-27632 improves the erectile dysfunction with ageing in SD rats through adjusting the imbalance between nNo and the Rho-kinase pathways.

Authors:  B H Gao; S T Zhao; F W Meng; B K Shi; Y Q Liu; Z S Xu
Journal:  Andrologia       Date:  2007-08       Impact factor: 2.775

9.  RhoA-mediated Ca2+ sensitization in erectile function.

Authors:  Hua Wang; Masumi Eto; William D Steers; Andrew P Somlyo; Avril V Somlyo
Journal:  J Biol Chem       Date:  2002-06-11       Impact factor: 5.157

10.  Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.

Authors:  Trinity J Bivalacqua; Biljana Musicki; Lewis L Hsu; Mark T Gladwin; Arthur L Burnett; Hunter C Champion
Journal:  J Sex Med       Date:  2009-06-11       Impact factor: 3.802

View more
  16 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 2.  Stuttering priapism: insights into pathogenesis and management.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

3.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

4.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

Review 5.  Understanding and targeting the Rho kinase pathway in erectile dysfunction.

Authors:  Nikolai A Sopko; Johanna L Hannan; Trinity J Bivalacqua
Journal:  Nat Rev Urol       Date:  2014-10-14       Impact factor: 14.432

6.  Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis.

Authors:  B Musicki; S Karakus; W Akakpo; F H Silva; J Liu; H Chen; B R Zirkin; A L Burnett
Journal:  Andrology       Date:  2017-11-16       Impact factor: 3.842

7.  Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Trinity J Bivalacqua; Hunter C Champion; Arthur L Burnett
Journal:  J Sex Med       Date:  2013-11-20       Impact factor: 3.802

Review 8.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

Review 9.  A pathophysiology-based approach to the management of early priapism.

Authors:  Jason R Kovac; Siu K Mak; Maurice M Garcia; Tom F Lue
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

10.  Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis.

Authors:  Gwen Lagoda; Sena F Sezen; Marcelo R Cabrini; Biljana Musicki; Arthur L Burnett
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.